✦ LIBER ✦

Efficacy of Nucleotide Polymerase Inhibitor Sofosbuvir Plus the NS5A Inhibitor Ledipasvir or the NS5B Non-Nucleoside Inhibitor GS-9669 Against HCV Genotype 1 Infection

✍ Scribed by Gane, Edward J.; Stedman, Catherine A.; Hyland, Robert H.; Ding, Xiao; Svarovskaia, Evguenia; Subramanian, G. Mani; Symonds, William T.; McHutchison, John G.; Pang, Phillip S.

Book ID: 121528294
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 585 KB
Volume: 146
Category: Article
ISSN: 0016-5085
DOI: 10.1053/j.gastro.2013.11.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P1242 RESISTANCE ANALYSIS OF HCV GENOTYP

P1242 RESISTANCE ANALYSIS OF HCV GENOTYPE 1 INFECTED PATIENTS TREATED WITH SOFOSBUVIR IN COMBINATION WITH LEDIPASVIR OR THE NS5B NONNUCLEOSIDE INHIBITOR GS-9669: THE ELECTRON STUDY

✍ Svarovskaia, E.S.; Martin, R.; Gontcharova, V.; Hyland, R.H.; Gane, E.J.; Stedma 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 55 KB

1206 NONCLINICAL AND CROSS-GENOTYPIC PRO

1206 NONCLINICAL AND CROSS-GENOTYPIC PROFILES OF GS-9669, A NOVEL HCV NS5B NON-NUCLEOSIDE THUMB SITE II INHIBITOR

✍ Fenaux, M.; Tian, Y.; Matles, M.; Mabery, E.; Zhang, Jingyu; Eng, S.; Murray, B. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

68 ANTIVIRAL EFFICACY OF THE NS3 PROTEAS

68 ANTIVIRAL EFFICACY OF THE NS3 PROTEASE INHIBITOR, GS-9451, NON-NUCLEOSIDE NS5b INHIBITOR, TEGOBUVIR, AND PEGYLATED INTERFERON PLUS RIBAVIRIN IN TREATMENT-NAÏVE GENOTYPE 1 HEPATITIS C INFECTED PATIENTS

✍ Pol, S.; Jablkowski, M.; Trenkle, J.D.; Kanwar, B.; Bekele, B.N.; Subramanian, M 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 57 KB

1193 RESISTANCE ANALYSES USING DEEP AND

1193 RESISTANCE ANALYSES USING DEEP AND POPULATION SEQUENCING AFTER 3 DAY MONOTHERAPY WITH GS-9669, A NOVEL NON-NUCLEOSIDE NS5B INHIBITOR IN GENOTYPE 1 HCV PATIENTS

✍ Dvory-Sobol, H.; Svarovskaia, E.S.; Gontcharova, V.; Rossi, S.; Lawitz, E.J.; Mi 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB

13 COMBINATION OF THE NS5A INHIBITOR, GS

13 COMBINATION OF THE NS5A INHIBITOR, GS-5885, THE NS3 PROTEASE INHIBITOR, GS-9451, AND PEGYLATED INTERFERON PLUS RIBAVIRIN IN TREATMENT EXPERIENCED PATIENTS WITH GENOTYPE 1 HEPATITIS C INFECTION

✍ Everson, G.T.; Di Bisceglie, A.M.; Vierling, J.M.; Hsieh, F.; Trenkle, J.D.; Kan 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Review article: the efficacy and safety

Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection

✍ Koff, R. S. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB